دورية أكاديمية

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults

التفاصيل البيبلوغرافية
العنوان: A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults
المؤلفون: Cummings, J.F., Polhemus, M.E., Kester, K.E., Ockenhouse, C.F., Gasser, R.A., Jr., Coyne, P., Wortmann, G., Nielsen, R.K., Schaecher, K., Holland, C.A., Krzych, U., Tornieporth, N., Soisson, L.A., Angov, E., Heppner, D.G.
المصدر: In Vaccine 30 April 2024 42(12):3066-3074
قاعدة البيانات: ScienceDirect
الوصف
تدمد:0264410X
DOI:10.1016/j.vaccine.2024.03.072